Breaking News Instant updates and real-time market news.

AKS

AK Steel

$5.33

(0.00%)

, CELG

Celgene

$106.09

3.36 (3.27%)

09:40
12/11/17
12/11
09:40
12/11/17
09:40

Unusually active option classes on open December 11th

Unusual total active option classes on open include: AK Steel (AKS), Celgene (CELG), GameStop (GME), CenturyLink (CTL), US Steel (X), and Oracle (ORCL).

AKS

AK Steel

$5.33

(0.00%)

CELG

Celgene

$106.09

3.36 (3.27%)

GME

GameStop

$19.20

(0.00%)

CTL

CenturyLink

$14.67

(0.00%)

X

U.S. Steel

$33.23

(0.00%)

ORCL

Oracle

$49.60

(0.00%)

  • 14

    Dec

  • 18

    Jan

  • 25

    Mar

AKS AK Steel
$5.33

(0.00%)

12/06/17
SBSH
12/06/17
NO CHANGE
SBSH
Citi sees limited near-term impact from Vietnam steel ruling
Department of Commerce found in favor of U.S. steel mills who claimed that certain imports of flat steel from Vietnam were circumventing existing duties on Chinese steel, Citi analyst Alexander Hacking wrote last night in a research note. The analyst, however, believes the ruling will not directly reduce near-term imports. He notes that imports from Vietnam have already fallen significantly. Nonetheless, Hacking calls the ruling a win for the U.S. steel industry as it sets a precedent for potential future cases in defining circumvention, defining material transformation and applying duties retroactively. He expects a "small positive reaction" in steel stocks today, with U.S. Steel (X) rallying the most, followed by AK Steel (AKS), Steel Dynamics (STLD) and Nucor (NUE)
12/07/17
JPMS
12/07/17
UPGRADE
Target $7
JPMS
Overweight
AK Steel upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Michael Gambardella upgraded AK Steel to Overweight and raised his price target for the shares to $7 from $6. The Department of Commerce's ruling against China redirecting steel to Vietnam will push steel prices higher in the U.S., Gambardella tells investors in a research note. He sees higher steel prices from tougher enforcement of trade laws more than offsetting the near-term cost pressures for AK Steel.
12/07/17
MSCO
12/07/17
NO CHANGE
MSCO
After Vietnam win, steel makers could file new complaints, says Morgan Stanley
Morgan Stanley analyst Piyush Sood said the Department of Commerce affirmative preliminary ruling against imports of certain steel products from Vietnam made of Chinese substrate may only affect small volumes, but it "sends a loud message to the steel industry" and could prompt U.S. steel makers to file similar complaints against other countries. He thinks a few self-initiated cases and anti circumvention cases can reduce U.S. steel imports and "clubbed together, could very well resemble a Section 232 ruling," though without an import quota and/or blanket tariffs. Falling imports next year should help boost prices, said Sood, who names U.S. Steel (X), AK Steel (AKS) and ArcelorMittal (MT) as "key beneficiaries," followed by Steel Dynamics (STLD)and Nucor (NUE).
12/07/17
12/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AK Steel (AKS) upgraded to Overweight from Neutral at JPMorgan with analyst Michael Gambardella saying the Department of Commerce's ruling against China redirecting steel to Vietnam will push steel prices higher in the U.S. 2. Shake Shack (SHAK) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst John Glass noting that the company has lifted its unit openings forecast in each of the last three years and is now growing company units at nearly 40%, which he points out is the fastest in the restaurant sector. 3. Hyatt (H) upgraded to Buy from Neutral at MKM Partners with analyst Christopher Agnew saying that GDP growth and leading economic indicators all point to stronger corporate activity in 2018, even as hotels are at record occupancy levels and supply growth is plateauing. 4. lululemon (LULU) upgraded to Hold from Sell at Canaccord with analyst Camilo Lyon saying his Sell thesis was predicated on a surging denim cycle that would take share from the athleisure wear cycle. 5. Wells Fargo (WFC) upgraded to Buy from Sell at Vertical Group. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CELG Celgene
$106.09

3.36 (3.27%)

12/08/17
ATLE
12/08/17
UPGRADE
ATLE
Overweight
Celgene upgraded to Overweight from Neutral at Atlantic Equities
12/05/17
ADAM
12/05/17
INITIATION
Target $202
ADAM
Buy
bluebird bio initiated with a Buy at Canaccord
Canaccord analyst John Newman initiated bluebird bio (BLUE) with a Buy rating citing its partnership with Celgene (CELG) and the long-term potential of bb2121, which could be used as an alternative or substitute for stem cell transplant in multiple myeloma. He also noted its improved process for its gene therapy product in addition to its drug pipeline. Newman has a $202 price target on bluebird bio shares.
12/08/17
JEFF
12/08/17
NO CHANGE
Target $125
JEFF
Buy
Jefferies positive on Celgene ahead of ASH conference
Jefferies analyst Michael Yee believes this weekend's American Society of Hematology conference should showcase Celgene's (CELG) CAR-T pipeline and possibly its PD-1 strategy. Further, the analyst sees Roche's (RHHBY) chemo-combo study as an incremental benefit. He notes that Roche's IMpower 130 and 131, which readout in the first half of 2018, both use Celgene's Abraxane as part of the chemo-combo instead of paclitaxel. Yee expects these trials to be positive as well, which should prove that Abraxane can be a chemo of choice in the chemo-combo regimens. Celgene is a "very reasonable" turnaround play for 2018, Yee tells investors in a research note. He believes the recent selloff is an overreaction and creates a buying opportunity "in time." The analyst has a Buy rating on the shares with a $125 price target.
12/10/17
PIPR
12/10/17
NO CHANGE
PIPR
Piper Jaffray remains bullish on BioMarin, Alexion following ASH
Piper Jaffray analyst Christopher Raymond remains Overweight rated on BioMarin (BMRN) and Alexion (ALXN), and Neutral rated on Celgene (CELG) following the American Society of Hematology Annual Meeting. Most notably, the analyst finds BioMarin's hemophilia gene therapy data with longer term data to be most impactful.
GME GameStop
$19.20

(0.00%)

11/22/17
FBCO
11/22/17
NO CHANGE
Target $20
FBCO
Neutral
GameStop profitability remains under pressure, says Credit Suisse
Credit Suisse analyst Seth Sigman notes that GameStop reported mixed results with relatively in line pro-forma adjusted EPS and higher sales growth offset by lower than expected gross margins and lower Tech Brands sales and profit. With the most important period ahead and continued margin challenges, the analyst reiterates a Neutral rating and $20 price target on the shares.
11/22/17
BARD
11/22/17
NO CHANGE
Target $23
BARD
Outperform
GameStop Q3 results better than feared, says Baird
Baird analyst Colin Sebastian said Q3 results from GameStop were better than feared as the digital headwinds were less pronounced during the quarter than what had been expected. The analyst noted results were driven by Switch-related new hardware strength and a continued ramp in collectibles. Sebastian maintained his Outperform rating and lowered his price target to $23 from $24 to reflect Tech Brands headwinds.
11/30/17
LOOP
11/30/17
NO CHANGE
Target $28
LOOP
Buy
GameStop rollout of Pokemon Centers makes "infinite sense", says Loop Capital
Loop Capital analyst Anthony Chukumba says GameStop decision to roll out Pokemon Centers at its GameStop and ThinkGeek stores adds to the company's larger collectibles initiative and "makes infinite sense" due to the popularity of the franchise. Chukumba keeps his Buy rating and $28 price target on GameStop, saying collectibles are a natural product extension for its business.
12/07/17
BARD
12/07/17
NO CHANGE
BARD
Data so far suggesting healthy holiday game sales, says Baird
Baird analyst Colin Sebastian noted that French game maker Ubisoft (UBSFY) raised its revenue and margin guidance for the December quarter, which he views as a slight positive for video game industry sales momentum this holiday season. Data also point to solid sales for both Sony's (SNE) PS4 and Nintendo's (NTDOY) Switch, which are a driver of software as well as a key catalyst for Gamestop (GME), Sebastian added. Other publicly traded companies in the video game space include Activision Blizzard (ATVI), Electronic Arts (EA), Take-Two (TTWO) and Microsoft (MSFT).
CTL CenturyLink
$14.67

(0.00%)

11/09/17
DBAB
11/09/17
NO CHANGE
Target $16
DBAB
Hold
CenturyLink keeping dividend an 'uphill battle,' says Deutsche Bank
Deutsche Bank analyst Matthew Niknam thinks the sustainability of CenturyLink's current dividend will remain in question until more meaningful inflections are seen in pro forma trends. In a post-earnings research note titled "Proving dividend sustainability will be an uphill battle," the analyst lowered his price target for the shares to $16 from $20 and keeps a Hold rating on CenturyLink.
11/09/17
JPMS
11/09/17
NO CHANGE
Target $26
JPMS
Overweight
CenturyLink shares to slowly rebound from here, says JPMorgan
JPMorgan analyst Philip Cusick believes CenturyLink shares were building in worse than the "soft" Q3 results and revenue outlook below the low-end of the previous range. CenturyLink maintained the current $2.16 dividend which implies a 13.3% yield, and all of the go-forward management emphasized their commitment to continuing to pay it, Cusick tells investors in a post-earnings research note. He believes a dividend cut was already built into the stock and expects shares to slowly rebound from current levels. The stock should be attractive to income-oriented investors, the analyst contends. He reiterates an Overweight rating on CenturyLink while trimming his price target to $26 from $28.
11/10/17
OPCO
11/10/17
NO CHANGE
Target $20
OPCO
Outperform
CenturyLink dividend cut logical, but unlikely, says Oppenheimer
At a 13% yield, it is logical for CenturyLink to cut the dividend in half to spend more on its network, but management is unlikely to do so, Oppenheimer analyst Timothy Horan tells investors in a research note. He now sees the payout ratio in the 80% range. CenturyLink is positioning itself to be a global, enterprise-focused company, which is the correct route, the analyst adds. He cut his price target for the shares to $20 from $28 and keeps an Outperform rating on the name.
11/28/17
GABE
11/28/17
NO CHANGE
Target $26
GABE
Buy
CenturyLink estimates lowered at Gabelli
Gabelli analyst Sergey Dluzhevskiy lowered CentruyLink estimate to reflect recent guidance and reduced revenue expectations and profitability for the legacy business. The analyst also lowered his valuation multiple to reflect the competitive environment, resulting in his private market value estimate moving to $26 from $29. Dluzhevskiy rates CenturyLink a Buy.
X U.S. Steel
$33.23

(0.00%)

11/02/17
11/02/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Yelp (YELP) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney saying the 5% after-market decline on lower fourth quarter outlook is not warranted since it is driven entirely by the Eat24 sale. 2. Domino's Pizza (DPZ) upgraded to Buy from Hold at Maxim with analyst Stephen Anderson saying that despite the 15% pullback in stock price, the company's fundamental trends remain solid. 3. U.S. Steel (X) upgraded to Market Perform from Underperform at Cowen with analyst Novid Rassouli telling investors the company's revitalization program has improved cost performance and driven stable financial results for two consecutive quarters. 4. FireEye (FEYE) upgraded to Buy from Neutral at Dougherty with analyst Catharine Trebnick saying FireEye reproted solid third quarter results across key financial metrics beating her estimates on sales execution, strong NX appliance refresh/renewals, endpoint sales and Mandiant services. 5. Newpark Resources (NR) upgraded to Buy from Hold at SunTrust with analyst Ken Sill saying the latest quarter did not show a hurricane related boost to mat rentals as the market expected, which should result in subsequent quarters growing from a higher base established in Q3 as well as an accretive acquisition announced this week. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/11/17
AXIO
12/11/17
UPGRADE
Target $37
AXIO
Hold
U.S. Steel upgraded to Hold from Sell at Axiom
Axiom analyst Gordon Johnson upgraded U.S. Steel to Hold with a $37 price target. The analyst believes protectionism from the Trump administration and positive seasonality could create a "more optimistic tone" in the near-term. He continues to believe, however, that U.S. Steel's free cash outlook is weak.
ORCL Oracle
$49.60

(0.00%)

11/03/17
BMOC
11/03/17
NO CHANGE
Target $40
BMOC
Market Perform
Teradata price target raised to $40 from $32 at BMO CapitalVMware
BMO Capital analyst Keith Bachman raised his price target on Teradata (TDC) to $40, saying the company's turnaround is driven by the buying capacity of existing customers. While Bachman believes the recurring product revenue growth is sustainable, he sees Oracle (ORCL) and VMware (VMW) as more attractively valued, keeping a Market Perform rating on Teradata.
11/09/17
UBSW
11/09/17
DOWNGRADE
Target $55
UBSW
Neutral
Oracle assumed with a Neutral from Buy at UBS
UBS analyst Jennifer Swanson Lowe downgraded Oracle to Neutral and lowered her price target for the shares to $55 from $57 after assuming coverage of the name. The analyst believes the stock at current levels leaves little room for error as the company transitions to the cloud. Further, she believes Street estimates do not fully reflect the near-term risk to margins or growth as the model shifts.
12/06/17
BARD
12/06/17
NO CHANGE
BARD
Baird identifies 13 areas of opportunity for Blockchain technology
Baird analyst Colin Sebastian has identified 13 areas of opportunity for Blockchain technology to have an impact. He sees Blockchain as platform enhancing in IoT, virtual goods, cloud storage, online gaming, and eSports. He sees the Blockchain as platform disruptive in online marketing, e-commerce, ride-sharing, digital music/media, and peer-to-peer payments. Sebastian believes technology companies will be talking more about it as they become more engaged in the areas he has mentioned and noted companies such as Amazon (AMZN), Oracle (ORCL) and VMware (VMW) have already recruited engineers with Blockchain experience.
12/06/17
RBCM
12/06/17
NO CHANGE
Target $53
RBCM
Outperform
Oracle price target lowered to $53 from $56 at RBC Capital
RBC Capital analyst Ross MacMillan lowered his price target on Oracle to $53, saying that his proprietary customer survey suggests that the company's cloud revenue and margins are slightly below consensus. MacMillan says that while the findings suggest that many of Oracle's customers find its technology stack remains relevant, modeling modest spending increases over the next 3 years, many customers also indicate that they do not use Oracle cloud services today and are unlikely to do so in the future. The analyst keeps his Outperform rating on Oracle, forecasting a 12% revenue growth and 42% operating margins.

TODAY'S FREE FLY STORIES

FB

Facebook

$183.81

-0.67 (-0.36%)

06:53
05/23/18
05/23
06:53
05/23/18
06:53
Periodicals
Facebook's upper ranks never seem to leave company, Recode reports »

Facebook's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

TIF

Tiffany

$102.26

-0.96 (-0.93%)

06:52
05/23/18
05/23
06:52
05/23/18
06:52
Hot Stocks
Breaking Hot Stocks news story on Tiffany »

Tiffany up 7.8% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

REGN

Regeneron

$294.72

-1.86 (-0.63%)

, SNY

Sanofi

$38.93

0.15 (0.39%)

06:52
05/23/18
05/23
06:52
05/23/18
06:52
Recommendations
Regeneron, Sanofi analyst commentary  »

Regeneron product…

REGN

Regeneron

$294.72

-1.86 (-0.63%)

SNY

Sanofi

$38.93

0.15 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Aug

  • 20

    Oct

  • 28

    Jan

MRK

Merck

$58.46

-0.1 (-0.17%)

06:52
05/23/18
05/23
06:52
05/23/18
06:52
Hot Stocks
Merck announces Keytruda met the dual primary endpoints in KEYNOTE trial »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

  • 23

    Oct

TIF

Tiffany

$102.26

-0.96 (-0.93%)

06:51
05/23/18
05/23
06:51
05/23/18
06:51
Earnings
Tiffany raises FY18 EPS view to $4.50-$4.70, consensus $4.42 »

Management's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

GDX

Market Vector Gold Miners

$22.12

-0.22 (-0.98%)

06:51
05/23/18
05/23
06:51
05/23/18
06:51
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$122.42

-0.05 (-0.04%)

06:50
05/23/18
05/23
06:50
05/23/18
06:50
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$24.47

-0.49 (-1.96%)

06:49
05/23/18
05/23
06:49
05/23/18
06:49
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$17.49

-0.01 (-0.06%)

, MSFT

Microsoft

$97.56

-0.04 (-0.04%)

06:49
05/23/18
05/23
06:49
05/23/18
06:49
Recommendations
HP Enterprise, Microsoft analyst commentary  »

HP Enterprise has…

HPE

HP Enterprise

$17.49

-0.01 (-0.06%)

MSFT

Microsoft

$97.56

-0.04 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 03

    Jun

  • 11

    Jun

  • 10

    Jul

TIF

Tiffany

$102.26

-0.96 (-0.93%)

06:49
05/23/18
05/23
06:49
05/23/18
06:49
Hot Stocks
Tiffany announces new $1B share repurchase program »

Tiffany's board has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$13.96

-0.48 (-3.32%)

06:49
05/23/18
05/23
06:49
05/23/18
06:49
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$24.92

0.68 (2.81%)

06:48
05/23/18
05/23
06:48
05/23/18
06:48
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$50.75

1.75 (3.57%)

06:48
05/23/18
05/23
06:48
05/23/18
06:48
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$34.61

0.33 (0.96%)

06:47
05/23/18
05/23
06:47
05/23/18
06:47
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIF

Tiffany

$102.26

-0.96 (-0.93%)

06:47
05/23/18
05/23
06:47
05/23/18
06:47
Earnings
Tiffany reports Q1 EPS $1.14, consensus 83c »

Reports Q1 revenue $1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

IGT

International Game

$28.47

-1.28 (-4.30%)

06:47
05/23/18
05/23
06:47
05/23/18
06:47
Recommendations
International Game analyst commentary  »

Deutsche Bank recommends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 23

    May

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$4.96

0.11 (2.27%)

06:46
05/23/18
05/23
06:46
05/23/18
06:46
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNE

Sony

$47.06

-1.32 (-2.73%)

06:46
05/23/18
05/23
06:46
05/23/18
06:46
Periodicals
Sony says next PlayStation is three years away, WSJ reports »

Sony wants to spend the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$13.44

-0.075 (-0.55%)

06:45
05/23/18
05/23
06:45
05/23/18
06:45
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$14.57

-0.1 (-0.68%)

06:45
05/23/18
05/23
06:45
05/23/18
06:45
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

06:45
05/23/18
05/23
06:45
05/23/18
06:45
General news
Breaking General news story  »

Week of 5/18 MBA Mortgage…

XOP

SPDR Oil Exploration and Production Fund

$43.07

-1.13 (-2.56%)

06:44
05/23/18
05/23
06:44
05/23/18
06:44
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$23.10

-1.88 (-7.53%)

06:43
05/23/18
05/23
06:43
05/23/18
06:43
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$75.42

-1.44 (-1.87%)

06:43
05/23/18
05/23
06:43
05/23/18
06:43
Hot Stocks
Target CEO says 'pleased' business generated strong traffic, sales growth in Q1 »

"We're very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 19

    Jun

UGAZ

VelocityShares 3x Long Natural Gas ETN

$65.89

4.69 (7.66%)

06:43
05/23/18
05/23
06:43
05/23/18
06:43
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.